All Articles

Navigating patients through the complexities of multiple myeloma can be very challenging – yet very rewarding.

Navigators’ Role in Education

By Jeri Lensing, OPN-CG

Navigation

January 2019 Vol 10, No 1

Offering nonclinical support to patients with cancer provides emotional support and helps to meet day-to-day needs.

Guiding Patients through Their Care Journey

By Jillian Burns, BSN, RN

Commentary

January 2019 Vol 10, No 1

A personal narrative about the learning curve of a new navigator who spent the past 10 years in an outpatient infusion clinic.

Survivorship Committee Update

By Nancy Corbitt, BSN, RN, OCN, CRNI

January 2019 Vol 10, No 1

The newly relaunched AONN+ Survivorship Committee asks 4 key questions of navigators that should drive survivorship care.

Kicking Off 2019

By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG

Letters from Lillie

January 2019 Vol 10, No 1

With great enthusiasm, I present to you the first issue of JONS in 2019!

Oncology Navigation: A Virtual Model to Promote Self-Advocacy in the Cancer Continuum

By Joyce Schaffer, MSN, RN, AOCNS; Susan G. Häag, PhD, MS; Erkut H. Borazanci, MD; David D. Von Hoff, MD

Original Research

January 2019 Vol 10, No 1

Virtual navigation may be a viable solution to reduce barriers to cancer care and increase patient outcomes, despite geographical location.

Biomarker-Guided Targeted Therapy in Breast Cancer: Best Practices from Community-Based Practitioners

By Harris S. Goodman, MD; Alan M. Kramer, MD

Best Practices in Immuno-Oncology Biomarker Testing December 2018 | Part 4 of a 4-Part Series

The target audience for this series includes physicians (medical and surgical oncologists, interventional radiologists), oncology nurse navigators, oncology nurses, pathologists, oncology pharmacists, and other stakeholders involved in delivering personalized care to cancer patients.

IWTI 2018 Video Series

Overcoming Challenges to Molecular Biomarker Testing

By Geoff Oxnard, MD; Lauren Ritterhouse, MD, PhD

Interview with the Innovators

Video Library

Drs. Geoffrey Oxnard and Lauren Ritterhouse discuss the challenges in biomarker testing—tissue stewardship and complexity of biomarker tests and results—and ways to overcome these challenges—improved communication among all members of the cancer care team and simplification of biomarker test results to focus on actionable biomarkers.

IWTI 2018 Video Series

Impact of Reimbursement for Biomarker Testing on Clinical Practice

By Geoff Oxnard, MD; Lauren Ritterhouse, MD, PhD

Interview with the Innovators

Video Library

Drs. Geoffrey Oxnard and Lauren Ritterhouse deliberate on ways reimbursement issues are impacting clinical practice, particularly CMS’s “14-Day Rule.”

IWTI 2018 Video Series

Reimbursement Challenges and Solutions with Molecular Biomarker Testing

By Geoff Oxnard, MD; Lauren Ritterhouse, MD, PhD

Interview with the Innovators

Video Library

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

All Articles

Page 185 of 283

Connect with Us

Subscribe Today!

I'd like to receive:

Please enter your mailing address.